RIM-TD open-label extension (OLE) study showed long-term improvement of Tardive Dyskinesia (TD) symptoms from treatment with deutetrabenazine ...

New data presented by Teva at ECNP 2024* demonstrate switching to UZEDY at four weeks after the last dose of once-monthly Perseris® (RBP-7000) provided the most comparable pharmacokinetic (PK) profile ...

Teva Pharmaceutical Industries Limited’s TEVA stock has risen 72.5% so far this year compared with an increase of 17.9% for ...

Teva, the world's largest generic drugmaker, will be hit with an EU antitrust fine in the coming weeks for disparaging a ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced new positive efficacy, safety and ...

Baltimore said on Tuesday that it has settled with Walgreens over claims that the pharmacy operator fueled opioid addiction ...

Teva Pharmaceutical Industries Ltd. is set to be hit with an antitrust fine from the European Union over allegations it tried ...

Baltimore secures an $80 million settlement with Teva Pharmaceuticals in its opioid crisis litigation. Funds will be ...

Teva is poised to benefit from rising demand for generic drugs due to a favorable macro and political environment. Learn more ...

The Fundamental Case for Teva Pharmaceutical Industries Limited American Depositary Shares TEVA Using a Price Based Model ...

Teva's reasonable valuation, an improving pipeline and the prospect of growth in sales and profits are good enough reasons for those who own the stock to stay invested. TEL AVIV, Israel ...